[HTML][HTML] Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID …

…, JV Divatia, S Saseedharan, K Borawake… - Intensive care …, 2022 - Springer
Purpose We compared dexamethasone 12 versus 6 mg daily for up to 10 days in patients
with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the international, …

[HTML][HTML] Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

…, JV Divatia, S Saseedharan, K Borawake… - Intensive care …, 2022 - Springer
Purpose We assessed long-term outcomes of dexamethasone 12 mg versus 6 mg given
daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe …

[HTML][HTML] Dengue encephalitis

K Borawake, P Prayag, A Wagh… - Indian Journal of Critical …, 2011 - ncbi.nlm.nih.gov
We report a case of dengue fever with features of encephalitis. The diagnosis of dengue was
confirmed by the serum antibodies to dengue and the presence of a dengue antigen in the …

Higher vs lower doses of dexamethasone in patients with COVID‐19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan

…, S Saseedharan, K Borawake… - Acta …, 2021 - Wiley Online Library
Background The coronavirus disease 2019 (COVID‐19) pandemic has resulted in millions
of deaths and overburdened healthcare systems worldwide. Systemic low‐dose …

[HTML][HTML] Anticoagulation in COVID–19: An update

…, S Melinkeri, A Ganapule, KS Borawake… - The Journal of Critical …, 2020 - sciendo.com
The novel coronavirus disease, 2019 (COVID–19) evolved as an unprecedented pandemic.
The severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) infection has been …

Higher vs lower doses of dexamethasone in patients with COVID‐19 and severe hypoxia (COVID STEROID 2) trial: protocol for a secondary Bayesian analysis

…, S Saseedharan, K Borawake… - Acta …, 2021 - Wiley Online Library
Background Coronavirus disease 2019 (COVID‐19) can lead to severe hypoxic respiratory
failure and death. Corticosteroids decrease mortality in severely or critically ill patients with …

[HTML][HTML] Noninvasive respiratory assist devices in the management of COVID-19-related hypoxic respiratory failure: Pune ISCCM COVID-19 ARDS Study Consortium …

…, K Kadapatti, J Shah, K Borawake… - Indian Journal of …, 2022 - ncbi.nlm.nih.gov
… Sameer Jog, corresponding author 1 Kapil Zirpe, 2 Subhal Dixit, 3 Purushotham
Godavarthy, 4 Manasi Shahane, 5 Kayanoosh Kadapatti, 6 Jignesh Shah, 7 Kapil Borawake …

[HTML][HTML] Bottle gourd (Lagenaria Siceraria) toxicity: A “bitter” diagnostic dilemma

KI Khatib, KS Borawake - Journal of Clinical and Diagnostic …, 2014 - ncbi.nlm.nih.gov
Consumption of a glass of bottle gourd juice is thought to work as a health “tonic” and part of
traditional healthy living practices in India. The juice may in certain circumstances turn bitter …

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial

…, A Padmanaban, N Bose, A Møller, K Borawake… - medRxiv, 2021 - medrxiv.org
IMPORTANCE Dexamethasone 6 mg daily is recommended for up to 10 days in patients
with severe and critical COVID-19, but a higher dose may benefit those with more severe …

[PDF][PDF] Retrospective cohort observational study to compare the effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID …

…, K Zirpe, P Suryawanshi, K Borawake… - J Assoc Physicians …, 2022 - researchgate.net
Background: COVID-19 has created enormous health crisis in India due to limited available
treatments. Majority of the physicians use sepsis as a prototype to understand the …